<DOC>
	<DOCNO>NCT01843023</DOCNO>
	<brief_summary>The purpose study compare 6-month treatment outcome 15-21 year old opioid-dependent youth receiving extend release naltrexone ( XR-NTX ) v. Treatment Usual ( TAU ) .</brief_summary>
	<brief_title>Extended Release Naltrexone Opioid-Dependent Youth</brief_title>
	<detailed_description>This propose study 6-month , two-group randomized clinical trial XR-NTX v. TAU 340 opioid-dependent youth age 15-21 . The study conduct Mountain Manor Treatment Center , community drug treatment program Baltimore . TAU consist buprenorphine treatment opioid withdrawal follow counsel without continued buprenorphine .</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Meets Diagnostic Statistical ManualIV criterion opioid dependence , physiologic subtype ; Within 3 day admission MMTC ; Age 15 21 , inclusive ; Able willing provide inform consent randomly assign XR NTX TAU ; participant 18 year age , parental guardian consent participant assent . Liver function test level ( Alanine Transaminase , Aspartate Transaminase ) four time great normal ; Unstable medical psychiatric illness ( e.g. , schizophrenia ) might make participation hazardous ; History serious suicide attempt past 6 month ; History allergic reaction naloxone , and/or naltrexone ; Current chronic pain condition opioids deem necessary ongoing care ; blood coagulation disorder ( e.g. , hemophilia ) ; Body Mass Index &gt; 40 ; If female , pregnant , lactating , unwilling unable ( due parental objection ) use FDAapproved contraceptive method ; meet DSMIV criterion benzodiazepine dependence</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>opioid dependence</keyword>
</DOC>